Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.

Neurosurgical review

Anghileri E, Castiglione M, Nunziata R, Boffano C, Nazzi V, Acerbi F, Finocchiaro G, Eoli M.
PMID: 26293175
Neurosurg Rev. 2015 Oct;38(4):773. doi: 10.1007/s10143-015-0668-5.

No abstract available.

Cite
Anghileri E, Castiglione M, Nunziata R, et al. Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev. 2015;38(4):773doi: 10.1007/s10143-015-0668-5.
Anghileri, E., Castiglione, M., Nunziata, R., Boffano, C., Nazzi, V., Acerbi, F., Finocchiaro, G., & Eoli, M. (2015). Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurgical review, 38(4), 773. https://doi.org/10.1007/s10143-015-0668-5
Anghileri, Elena, et al. "Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature." Neurosurgical review vol. 38,4 (2015): 773. doi: https://doi.org/10.1007/s10143-015-0668-5
Anghileri E, Castiglione M, Nunziata R, Boffano C, Nazzi V, Acerbi F, Finocchiaro G, Eoli M. Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev. 2015 Oct;38(4):773. doi: 10.1007/s10143-015-0668-5. PMID: 26293175.
Copy Download .nbib Format: NLM
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8.

Oncoimmunology

Pellegatta S, Eoli M, Cuccarini V, Anghileri E, Pollo B, Pessina S, Frigerio S, Servida M, Cuppini L, Antozzi C, Cuzzubbo S, Corbetta C, Paterra R, Acerbi F, Ferroli P, DiMeco F, Fariselli L, Parati EA, Bruzzone MG, Finocchiaro G.
PMID: 29632727
Oncoimmunology. 2018 Jan 29;7(4):e1412901. doi: 10.1080/2162402X.2017.1412901. eCollection 2018.

In a two-stage phase II study, 24 patients with first diagnosis of glioblastoma (GBM) were treated with dendritic cell (DC) immunotherapy associated to standard radiochemotherapy with temozolomide (TMZ) followed by adjuvant TMZ. Three intradermal injections of mature DC loaded...

Cite
Pellegatta S, Eoli M, Cuccarini V, et al. Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8. Oncoimmunology. 2018;7(4):e1412901doi: 10.1080/2162402X.2017.1412901.
Pellegatta, S., Eoli, M., Cuccarini, V., Anghileri, E., Pollo, B., Pessina, S., Frigerio, S., Servida, M., Cuppini, L., Antozzi, C., Cuzzubbo, S., Corbetta, C., Paterra, R., Acerbi, F., Ferroli, P., DiMeco, F., Fariselli, L., Parati, E. A., Bruzzone, M. G., & Finocchiaro, G. (2018). Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8. Oncoimmunology, 7(4), e1412901. https://doi.org/10.1080/2162402X.2017.1412901
Pellegatta, Serena, et al. "Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8." Oncoimmunology vol. 7,4 (2018): e1412901. doi: https://doi.org/10.1080/2162402X.2017.1412901
Pellegatta S, Eoli M, Cuccarini V, Anghileri E, Pollo B, Pessina S, Frigerio S, Servida M, Cuppini L, Antozzi C, Cuzzubbo S, Corbetta C, Paterra R, Acerbi F, Ferroli P, DiMeco F, Fariselli L, Parati EA, Bruzzone MG, Finocchiaro G. Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8. Oncoimmunology. 2018 Jan 29;7(4):e1412901. doi: 10.1080/2162402X.2017.1412901. eCollection 2018. PMID: 29632727; PMCID: PMC5889286.
Copy Download .nbib Format: NLM
Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.

Cancers

Anghileri E, Patanè M, Di Ianni N, Sambruni I, Maffezzini M, Milani M, Maddaloni L, Pollo B, Eoli M, Pellegatta S.
PMID: 34944776
Cancers (Basel). 2021 Dec 07;13(24). doi: 10.3390/cancers13246156.

The interpretation of the presence and function of immune infiltration in glioblastoma (GBM) is still debated. Over the years, GBM has been considered a cold tumor that is less infiltrated by effector cells and characterized by a high proportion...

Cite
Anghileri E, Patanè M, Di Ianni N, et al. Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches. Cancers (Basel). 2021;13(24)doi: 10.3390/cancers13246156.
Anghileri, E., Patanè, M., Di Ianni, N., Sambruni, I., Maffezzini, M., Milani, M., Maddaloni, L., Pollo, B., Eoli, M., & Pellegatta, S. (2021). Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches. Cancers, 13(24), . https://doi.org/10.3390/cancers13246156
Anghileri, Elena, et al. "Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches." Cancers vol. 13,24 (2021). doi: https://doi.org/10.3390/cancers13246156
Anghileri E, Patanè M, Di Ianni N, Sambruni I, Maffezzini M, Milani M, Maddaloni L, Pollo B, Eoli M, Pellegatta S. Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches. Cancers (Basel). 2021 Dec 07;13(24). doi: 10.3390/cancers13246156. PMID: 34944776.
Copy Download .nbib Format: NLM
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis.

Therapeutic advances in chronic disease

Ferrucci S, Romagnuolo M, Maronese CA, Germiniasi F, Tavecchio S, Angileri L, Casazza G, Marzano AV, Genovese G.
PMID: 34900210
Ther Adv Chronic Dis. 2021 Dec 06;12:20406223211058332. doi: 10.1177/20406223211058332. eCollection 2021.

BACKGROUND: Atopic dermatitis (AD) is a common chronic-relapsing inflammatory skin disease hallmarked by epidermal barrier dysfunction, increased transepidermal water loss (TEWL) and decreased skin hydration. Recent findings on the T helper 2 (Th2)-driven pathogenesis of AD have led to...

Cite
Ferrucci S, Romagnuolo M, Maronese CA, et al. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Ther Adv Chronic Dis. 2021;12:20406223211058332doi: 10.1177/20406223211058332.
Ferrucci, S., Romagnuolo, M., Maronese, C. A., Germiniasi, F., Tavecchio, S., Angileri, L., Casazza, G., Marzano, A. V., & Genovese, G. (2021). Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Therapeutic advances in chronic disease, 1220406223211058332. https://doi.org/10.1177/20406223211058332
Ferrucci, Silvia, et al. "Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis." Therapeutic advances in chronic disease vol. 12 (2021): 20406223211058332. doi: https://doi.org/10.1177/20406223211058332
Ferrucci S, Romagnuolo M, Maronese CA, Germiniasi F, Tavecchio S, Angileri L, Casazza G, Marzano AV, Genovese G. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Ther Adv Chronic Dis. 2021 Dec 06;12:20406223211058332. doi: 10.1177/20406223211058332. eCollection 2021. PMID: 34900210; PMCID: PMC8655442.
Copy Download .nbib Format: NLM
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis.

Quantitative imaging in medicine and surgery

Schettino C, Caranci F, Lus G, Signoriello E, Eoli M, Anghileri E, Pollo B, Melone MAB, Di Iorio G, Finocchiaro G, Ugga L, Tedeschi E.
PMID: 29184769
Quant Imaging Med Surg. 2017 Oct;7(5):592-597. doi: 10.21037/qims.2017.06.09.

We report the case of a young man with sudden onset of diplopia after an upper respiratory tract infection. Based on the first radiological findings acute hemorrhagic leukoencephalitis, a variant of acute disseminated encephalomyelitis, was suspected and treatment with...

Cite
Schettino C, Caranci F, Lus G, et al. Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis. Quant Imaging Med Surg. 2017;7(5):592-597doi: 10.21037/qims.2017.06.09.
Schettino, C., Caranci, F., Lus, G., Signoriello, E., Eoli, M., Anghileri, E., Pollo, B., Melone, M. A. B., Di Iorio, G., Finocchiaro, G., Ugga, L., & Tedeschi, E. (2017). Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis. Quantitative imaging in medicine and surgery, 7(5), 592-597. https://doi.org/10.21037/qims.2017.06.09
Schettino, Carla, et al. "Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis." Quantitative imaging in medicine and surgery vol. 7,5 (2017): 592-597. doi: https://doi.org/10.21037/qims.2017.06.09
Schettino C, Caranci F, Lus G, Signoriello E, Eoli M, Anghileri E, Pollo B, Melone MAB, Di Iorio G, Finocchiaro G, Ugga L, Tedeschi E. Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis. Quant Imaging Med Surg. 2017 Oct;7(5):592-597. doi: 10.21037/qims.2017.06.09. PMID: 29184769; PMCID: PMC5682395.
Copy Download .nbib Format: NLM
Treatment of hookworm-related cutaneous larva migrans with topical ivermectin.

The Journal of dermatological treatment

Veraldi S, Angileri L, Parducci BA, Nazzaro G.
PMID: 27687255
J Dermatolog Treat. 2017 May;28(3):263. doi: 10.1080/09546634.2016.1214669. Epub 2016 Aug 10.

No abstract available.

Cite
Veraldi S, Angileri L, Parducci BA, et al. Treatment of hookworm-related cutaneous larva migrans with topical ivermectin. J Dermatolog Treat. 2016;28(3):263doi: 10.1080/09546634.2016.1214669.
Veraldi, S., Angileri, L., Parducci, B. A., & Nazzaro, G. (2017). Treatment of hookworm-related cutaneous larva migrans with topical ivermectin. The Journal of dermatological treatment, 28(3), 263. https://doi.org/10.1080/09546634.2016.1214669
Veraldi, Stefano, et al. "Treatment of hookworm-related cutaneous larva migrans with topical ivermectin." The Journal of dermatological treatment vol. 28,3 (2017): 263. doi: https://doi.org/10.1080/09546634.2016.1214669
Veraldi S, Angileri L, Parducci BA, Nazzaro G. Treatment of hookworm-related cutaneous larva migrans with topical ivermectin. J Dermatolog Treat. 2017 May;28(3):263. doi: 10.1080/09546634.2016.1214669. Epub 2016 Aug 10. PMID: 27687255.
Copy Download .nbib Format: NLM
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Clinical and molecular allergy : CMA

Di Agosta E, Salvati L, Corazza M, Baiardini I, Ambrogio F, Angileri L, Antonelli E, Belluzzo F, Bonamonte D, Bonzano L, Brancaccio R, Custurone P, De Marco A, Detoraki A, Di Guida A, Di Leo E, Fantò M, Fassio F, Ferrucci SM, Foti C, Gallo R, Gatta A, Guarneri F, Guidolin L, Hansel K, Lamacchia D, Lombardo C, Minciullo PL, Napolitano M, Pannofino A, Paravisi A, Parente R, Passante M, Patruno C, Peroni D, Quecchia C, Schettini N, Spadaro G, Stingeni L, Tarrini D, Tramontana M, Nettis E, Rossi O.
PMID: 34930291
Clin Mol Allergy. 2021 Dec 20;19(1):26. doi: 10.1186/s12948-021-00165-6.

Allergic and immunologic skin diseases negatively impact the quality of life (QoL) of affected patients with detrimental consequences. Nonetheless, in everyday clinical practice the evaluation of QoL is often overlooked. Considering the increasing prevalence of atopic dermatitis, allergic contact...

Cite
Di Agosta E, Salvati L, Corazza M, et al. Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder. Clin Mol Allergy. 2021;19(1):26doi: 10.1186/s12948-021-00165-6.
Di Agosta, E., Salvati, L., Corazza, M., Baiardini, I., Ambrogio, F., Angileri, L., Antonelli, E., Belluzzo, F., Bonamonte, D., Bonzano, L., Brancaccio, R., Custurone, P., De Marco, A., Detoraki, A., Di Guida, A., Di Leo, E., Fantò, M., Fassio, F., Ferrucci, S. M., Foti, C., Gallo, R., Gatta, A., Guarneri, F., Guidolin, L., Hansel, K., Lamacchia, D., Lombardo, C., Minciullo, P. L., Napolitano, M., Pannofino, A., Paravisi, A., Parente, R., Passante, M., Patruno, C., Peroni, D., Quecchia, C., Schettini, N., Spadaro, G., Stingeni, L., Tarrini, D., Tramontana, M., Nettis, E., & Rossi, O. (2021). Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder. Clinical and molecular allergy : CMA, 19(1), 26. https://doi.org/10.1186/s12948-021-00165-6
Di Agosta, Ester, et al. "Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder." Clinical and molecular allergy : CMA vol. 19,1 (2021): 26. doi: https://doi.org/10.1186/s12948-021-00165-6
Di Agosta E, Salvati L, Corazza M, Baiardini I, Ambrogio F, Angileri L, Antonelli E, Belluzzo F, Bonamonte D, Bonzano L, Brancaccio R, Custurone P, De Marco A, Detoraki A, Di Guida A, Di Leo E, Fantò M, Fassio F, Ferrucci SM, Foti C, Gallo R, Gatta A, Guarneri F, Guidolin L, Hansel K, Lamacchia D, Lombardo C, Minciullo PL, Napolitano M, Pannofino A, Paravisi A, Parente R, Passante M, Patruno C, Peroni D, Quecchia C, Schettini N, Spadaro G, Stingeni L, Tarrini D, Tramontana M, Nettis E, Rossi O. Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder. Clin Mol Allergy. 2021 Dec 20;19(1):26. doi: 10.1186/s12948-021-00165-6. PMID: 34930291.
Copy Download .nbib Format: NLM
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis.

Therapeutic advances in chronic disease

Ferrucci S, Romagnuolo M, Maronese CA, Germiniasi F, Tavecchio S, Angileri L, Casazza G, Marzano AV, Genovese G.
PMID: 34900210
Ther Adv Chronic Dis. 2021 Dec 06;12:20406223211058332. doi: 10.1177/20406223211058332. eCollection 2021.

BACKGROUND: Atopic dermatitis (AD) is a common chronic-relapsing inflammatory skin disease hallmarked by epidermal barrier dysfunction, increased transepidermal water loss (TEWL) and decreased skin hydration. Recent findings on the T helper 2 (Th2)-driven pathogenesis of AD have led to...

Cite
Ferrucci S, Romagnuolo M, Maronese CA, et al. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Ther Adv Chronic Dis. 2021;12:20406223211058332doi: 10.1177/20406223211058332.
Ferrucci, S., Romagnuolo, M., Maronese, C. A., Germiniasi, F., Tavecchio, S., Angileri, L., Casazza, G., Marzano, A. V., & Genovese, G. (2021). Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Therapeutic advances in chronic disease, 1220406223211058332. https://doi.org/10.1177/20406223211058332
Ferrucci, Silvia, et al. "Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis." Therapeutic advances in chronic disease vol. 12 (2021): 20406223211058332. doi: https://doi.org/10.1177/20406223211058332
Ferrucci S, Romagnuolo M, Maronese CA, Germiniasi F, Tavecchio S, Angileri L, Casazza G, Marzano AV, Genovese G. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis. Ther Adv Chronic Dis. 2021 Dec 06;12:20406223211058332. doi: 10.1177/20406223211058332. eCollection 2021. PMID: 34900210; PMCID: PMC8655442.
Copy Download .nbib Format: NLM
Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection.

Children (Basel, Switzerland)

Rock NM, Anghileri E, Cousin VL, Petit LM, McLin VA.
PMID: 34356591
Children (Basel). 2021 Jul 20;8(7). doi: 10.3390/children8070612.

No abstract available.

Cite
Rock NM, Anghileri E, Cousin VL, et al. Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection. Children (Basel). 2021;8(7)doi: 10.3390/children8070612.
Rock, N. M., Anghileri, E., Cousin, V. L., Petit, L. M., & McLin, V. A. (2021). Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection. Children (Basel, Switzerland), 8(7), . https://doi.org/10.3390/children8070612
Rock, Nathalie M, et al. "Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection." Children (Basel, Switzerland) vol. 8,7 (2021). doi: https://doi.org/10.3390/children8070612
Rock NM, Anghileri E, Cousin VL, Petit LM, McLin VA. Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection. Children (Basel). 2021 Jul 20;8(7). doi: 10.3390/children8070612. PMID: 34356591; PMCID: PMC8306001.
Copy Download .nbib Format: NLM
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Clinical and molecular allergy : CMA

Di Agosta E, Salvati L, Corazza M, Baiardini I, Ambrogio F, Angileri L, Antonelli E, Belluzzo F, Bonamonte D, Bonzano L, Brancaccio R, Custurone P, De Marco A, Detoraki A, Di Guida A, Di Leo E, Fantò M, Fassio F, Ferrucci SM, Foti C, Gallo R, Gatta A, Guarneri F, Guidolin L, Hansel K, Lamacchia D, Lombardo C, Minciullo PL, Napolitano M, Pannofino A, Paravisi A, Parente R, Passante M, Patruno C, Peroni D, Quecchia C, Schettini N, Spadaro G, Stingeni L, Tarrini D, Tramontana M, Nettis E, Rossi O.
PMID: 34930291
Clin Mol Allergy. 2021 Dec 20;19(1):26. doi: 10.1186/s12948-021-00165-6.

Allergic and immunologic skin diseases negatively impact the quality of life (QoL) of affected patients with detrimental consequences. Nonetheless, in everyday clinical practice the evaluation of QoL is often overlooked. Considering the increasing prevalence of atopic dermatitis, allergic contact...

Cite
Di Agosta E, Salvati L, Corazza M, et al. Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder. Clin Mol Allergy. 2021;19(1):26doi: 10.1186/s12948-021-00165-6.
Di Agosta, E., Salvati, L., Corazza, M., Baiardini, I., Ambrogio, F., Angileri, L., Antonelli, E., Belluzzo, F., Bonamonte, D., Bonzano, L., Brancaccio, R., Custurone, P., De Marco, A., Detoraki, A., Di Guida, A., Di Leo, E., Fantò, M., Fassio, F., Ferrucci, S. M., Foti, C., Gallo, R., Gatta, A., Guarneri, F., Guidolin, L., Hansel, K., Lamacchia, D., Lombardo, C., Minciullo, P. L., Napolitano, M., Pannofino, A., Paravisi, A., Parente, R., Passante, M., Patruno, C., Peroni, D., Quecchia, C., Schettini, N., Spadaro, G., Stingeni, L., Tarrini, D., Tramontana, M., Nettis, E., & Rossi, O. (2021). Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder. Clinical and molecular allergy : CMA, 19(1), 26. https://doi.org/10.1186/s12948-021-00165-6
Di Agosta, Ester, et al. "Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder." Clinical and molecular allergy : CMA vol. 19,1 (2021): 26. doi: https://doi.org/10.1186/s12948-021-00165-6
Di Agosta E, Salvati L, Corazza M, Baiardini I, Ambrogio F, Angileri L, Antonelli E, Belluzzo F, Bonamonte D, Bonzano L, Brancaccio R, Custurone P, De Marco A, Detoraki A, Di Guida A, Di Leo E, Fantò M, Fassio F, Ferrucci SM, Foti C, Gallo R, Gatta A, Guarneri F, Guidolin L, Hansel K, Lamacchia D, Lombardo C, Minciullo PL, Napolitano M, Pannofino A, Paravisi A, Parente R, Passante M, Patruno C, Peroni D, Quecchia C, Schettini N, Spadaro G, Stingeni L, Tarrini D, Tramontana M, Nettis E, Rossi O. Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder. Clin Mol Allergy. 2021 Dec 20;19(1):26. doi: 10.1186/s12948-021-00165-6. PMID: 34930291; PMCID: PMC8690422.
Copy Download .nbib Format: NLM
Hookworm-related cutaneous larva migrans: our 201st patient.

Journal of infection in developing countries

Nazzaro G, Angileri L, Parducci BA, Veraldi S.
PMID: 30943183
J Infect Dev Ctries. 2017 Jun 01;11(5):437-439. doi: 10.3855/jidc.8930.

No abstract available.

Cite
Nazzaro G, Angileri L, Parducci BA, et al. Hookworm-related cutaneous larva migrans: our 201st patient. J Infect Dev Ctries. 2017;11(5):437-439doi: 10.3855/jidc.8930.
Nazzaro, G., Angileri, L., Parducci, B. A., & Veraldi, S. (2017). Hookworm-related cutaneous larva migrans: our 201st patient. Journal of infection in developing countries, 11(5), 437-439. https://doi.org/10.3855/jidc.8930
Nazzaro, Gianluca, et al. "Hookworm-related cutaneous larva migrans: our 201st patient." Journal of infection in developing countries vol. 11,5 (2017): 437-439. doi: https://doi.org/10.3855/jidc.8930
Nazzaro G, Angileri L, Parducci BA, Veraldi S. Hookworm-related cutaneous larva migrans: our 201st patient. J Infect Dev Ctries. 2017 Jun 01;11(5):437-439. doi: 10.3855/jidc.8930. PMID: 30943183.
Copy Download .nbib Format: NLM
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience.

Journal of clinical medicine

Ferrucci S, Casazza G, Angileri L, Tavecchio S, Germiniasi F, Berti E, Marzano AV, Genovese G.
PMID: 32183179
J Clin Med. 2020 Mar 13;9(3). doi: 10.3390/jcm9030791.

Dupilumab is an anti-interleukin-4 receptor monoclonal antibody that was recently approved for the treatment of atopic dermatitis (AD). In this single-center retrospective study, clinical baseline data of 117 severe AD patients treated with dupilumab were collected. At baseline and...

Cite
Ferrucci S, Casazza G, Angileri L, et al. Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience. J Clin Med. 2020;9(3)doi: 10.3390/jcm9030791.
Ferrucci, S., Casazza, G., Angileri, L., Tavecchio, S., Germiniasi, F., Berti, E., Marzano, A. V., & Genovese, G. (2020). Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience. Journal of clinical medicine, 9(3), . https://doi.org/10.3390/jcm9030791
Ferrucci, Silvia, et al. "Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience." Journal of clinical medicine vol. 9,3 (2020). doi: https://doi.org/10.3390/jcm9030791
Ferrucci S, Casazza G, Angileri L, Tavecchio S, Germiniasi F, Berti E, Marzano AV, Genovese G. Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience. J Clin Med. 2020 Mar 13;9(3). doi: 10.3390/jcm9030791. PMID: 32183179; PMCID: PMC7141229.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries